EP3908270
SAMSETNING DEXTROMETHORPHAN OG BUPROPION TIL MEÐFERÐAR Á ÞUNGLYNDI HJÁ ASÍSKUM SJÚKLINGUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.1.2020EP published:
27.8.2025EP application number:
20737928.0
EP translation filed:
17.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
6.1.2040Expiry date:
6.1.2027Next due date:
31.1.2027
Title in English:
COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION IN ASIAN PATIENTSLanguage of the patent:
English
Timeline
Today
7.1.2020EP application
27.8.2025EP Publication
17.11.2025Translation submitted
15.12.2025Registration published
6.1.2027Expires
Owner
Name:
Antecip Bioventures II LLCAddress:
630 Fifth Avenue, Suite 2000, New York, NY 10111, US
Inventor
Name:
TABUTEAU, HerriotAddress:
New York, New York 10007, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201962789431 PDate:
7.1.2019Country:
US
Number:
201962789446 PDate:
7.1.2019Country:
US
Number:
201962789451 PDate:
7.1.2019Country:
US
Number:
201962789488 PDate:
7.1.2019Country:
US
Classification
Categories:
A61K 31/137, A61K 31/485, A61P 25/24
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.2.2026
Expires: 6.1.2027
Payer: Árnason Faktor ehf.